date:Jul 31, 2014
he overuse of antibiotics in food animal production and what additional actions FDA plans to take if this overuse continues.
In a final guidance issued Dec. 11, 2013, the FDA laid out a plan for animal-pharmaceutical companies to voluntarily revise the FDA-approved use conditions on the labels of products to remove such production indications as growth promoting, etc. The plan also calls for changing the current over-the-counter status to bring the remaining appropriate therapeutic uses under v